A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Conditions

• Malignant Rhabdoid Tumors (MRT)
• Rhabdoid Tumors of the Kidney (RTK)
• Atypical Teratoid Rhabdoid Tumors (ATRT)
• Selected Tumors With Rhabdoid Features
• Synovial Sarcoma
• INI1-negative Tumors
• Malignant Rhabdoid Tumor of Ovary
• Renal Medullary Carcinoma
• Epithelioid Sarcoma
• Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval)
• Any Solid Tumor With an EZH2 GOF Mutation

Interventions

• DRUG: Tazemetostat

Sponsor

Epizyme, Inc.